Jenny Minigh

Meet our Executive Vice President, Medical Writing

Read More...

Rare Disease Clinical Endpoints: Ingenuity Meets Practicality

Discover why the science that brought you to this point can only […]

Read More...

CRAs Must Evolve Alongside Oncology Therapeutics

Clinical Research Associates (CRAs) must adapt to the evolving demands of oncology […]

Read More...

Crissy Reynolds

Meet our Senior Director, Regulatory Operations

Read More...

Raul P. Lima

Meet our Executive Vice President, Clinical Operations

Read More...

Karin Rezzonico

Meet our Senior Director, Quality Assurance & Compliance

Read More...

Our message to CMOs

For over 12 years, we’ve stood alongside the Chief Medical Officer Summit […]

Read More...

FDA Update on ICH E6, E8, QbD and RBM in Clinical Trials

Integrating Quality by Design (QbD) and Risk-Based Monitoring (RBM) approaches in clinical […]

Read More...

Revolutionizing Clinical Trials: The Power And Potential Of Risk-Based Monitoring

The article explores the benefits and misconceptions of risk-based monitoring (RBM) in […]

Read More...

How Sponsors and Patients Benefit From a Site-Centric Partnership

Site-centric partnerships between sponsors and clinical trial sites can significantly enhance patient […]

Read More...